WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014

Jan 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-01-17

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-17	Common Stock	F	8523.0000	$49.6900	Disposed	977736.3732	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2683.4400	Indirect
Common Stock	17306.9142	Indirect

Footnotes

F1: Change in the amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualified Deferred Compensation Plan for Designated Employees. These deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant.

F2: Change in amount of securities beneficially owned is due to change of form of ownership from indirect to direct due to the distribution of vested deferred stock units credited to the participant's account under the terms of the Nonqualified Deferred Compensation Plan for Designated Employees. 24,458 of these deferred stock units were distributed in the form of unrestricted whole shares of stock and are now held directly by the participant and $35.75 was distributed to the participant in cash.